scPharmaceuticals Inc. (NASDAQ:SCPH) finished Friday with an addition of $0.1 to close at $7.85, an upside of 1.29 percent. An average of 458,340 shares of common stock have been traded in the last five days. There was a fall of -$0.32 in the past week, and it reached a new high 18 times over the past 12 months. The last 20 days have seen an average of 316,800 shares traded, while the 50-day average volume stands at 476,346.
SCPH stock has decreased by -7.65% in the last month. The company shares reached their 1-month lowest point of $7.32 on 08/11/23. With the stock rallying to its 52-week high on 05/11/23, shares of the company touched a low of $3.68 and a high of $12.75 in 52 weeks. It has reached a new high 10 times so far this year and achieved 9.48% or $0.68 in price. In spite of this, the price is down -38.43% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
SCPH stock investors should be aware that scPharmaceuticals Inc. (SCPH) stock had its last reported insider trading activity 306 days ago on Nov 25. In this transaction, the insider spent $2,300,486. 10% Owner, 5AM Partners IV, LLC, disposed of 37,534 shares at a price of $5.02 on Oct 06. The insider now owns more than $188,421 worth of shares. Prior to that, 10% Owner 5AM Partners IV, LLC went on to Sale 200,000 shares at $4.75 each on Sep 07. An amount of $950,000 was transacted.
Valuation Metrics
scPharmaceuticals Inc. (SCPH) stock’s beta is 0.18. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 134.83, the price-to-book (PB) ratio at 3.91.
Financial Health
The quick ratio of scPharmaceuticals Inc. for the three months ended June 29 was 15.90, and the current ratio was 16.40, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.49 and a total debt to equity ratio of 0.00 for the quarter ending June 29. Its gross profit as reported stood at $3.3 million compared to revenue of $36.16 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, scPharmaceuticals Inc.’s return on assets was -44.90%.
Earnings Surprise
For the three-month period that ended June 29, scPharmaceuticals Inc. had $31.53 million in cash and short-term investments compared to $37.74 million in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of -$14.15 million in the quarter, while revenues of -$11.21 million were grew 31.45%. The analyst consensus anticipated scPharmaceuticals Inc.’s latest quarter earnings to come in at -$0.37 per share, but it turned out to be -$0.36, a 2.70% surprise. For the quarter, EBITDA amounted to -$13.64 million. At the end of the quarter ending June 29, scPharmaceuticals Inc.’s stock balance sheet showed total liabilities of 50.74 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at scPharmaceuticals Inc. (SCPH) price momentum. RSI 9-day as of the close on 11 August was 33.75%, suggesting the stock is Neutral, with historical volatility in this time frame at 25.56%.
As of today, SCPH’s price is $7.83 -3.92% or -$0.32 from its 5-day moving average. SCPH is currently trading -6.10% lower than its 20-day SMA and +14.26% higher than its 100-day SMA. However, the stock’s current price level is -26.08% below the SMA50 and +46.46% above the SMA200.
The stochastic %K and %D were 23.33% and 16.05%, respectively, and the average true range (ATR) was 0.42. With the 14-day stochastic at 43.32% and the average true range at 0.43, the RSI (14) stands at 34.54%. The stock has reached -0.19 on the 9-day MACD Oscillator while the 14-day reading was at -0.28.
Analyst Ratings
Cowen launched coverage on scPharmaceuticals Inc. (NASDAQ: SCPH) in its analyst report released on December 01, 2022. The firm assigned the stock an Outperform rating. The consensus rating for scPharmaceuticals Inc. (SCPH) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell SCPH, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 5 others rate it as a “buy”.
What is SCPH’s price target for the next 12 months?
Analysts predict a range of price targets between $16.00 and $25.00, with a median target of $18.00. Taking a look at these predictions, the average price target given by analysts for scPharmaceuticals Inc. (SCPH) stock is $19.20.
